phenotype

NEUROINFLAMMATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10630Connections

30Hypotheses

27Analyses

50Outgoing

50Incoming

4Experiments

20Debates

Summary

NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.

View on Wiki →

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Immune Atlas: Neuroinflammation Analysis

analysis · 0 words

→

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
        CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    subgraph Pathology["Pathology"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
        APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4208)

Target	Relation	Type	Str
Dementia	associated_with	disease	1.00
Alzheimer	causes	disease	1.00
NEURODEGENERATION	activates	phenotype	1.00
Neurodegeneration	causes	disease	1.00
MICROGLIA	inhibits	gene	1.00
Neurodegeneration	causes	disease	1.00
Toll-Like Receptor	activates	pathway	1.00
Neurodegeneration	activates	disease	1.00
Autophagy	activates	pathway	1.00
Stroke	regulates	disease	1.00
Oxidative Stress	activates	pathway	1.00
Mitophagy	activates	pathway	1.00
Nf-Κb	inhibits	pathway	1.00
Aging	associated_with	disease	1.00
Tumor	activates	disease	1.00
Blood-Brain Barrier	associated_with	pathway	1.00
Neuroinflammation	biomarker_for	disease	1.00
Neurodegeneration	activates	process	1.00
Oxidative Stress	activates	pathway	1.00
Inflammation	biomarker_for	disease	1.00
Apoptosis	activates	pathway	1.00
Nf-Κb	activates	pathway	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
DEMENTIA	associated_with	gene	1.00
Immune Response	therapeutic_target	pathway	1.00
MICROGLIA	associated_with	gene	1.00
Immune Response	therapeutic_target	pathway	1.00
STROKE	associated_with	gene	1.00
Pi3K/Akt	activates	pathway	1.00
Neurodegeneration	regulates	disease	1.00
Alzheimer	regulates	disease	1.00
Depression	activates	disease	1.00
Pi3K/Akt	activates	pathway	1.00
Als	activates	disease	1.00
Dementia	activates	disease	1.00
Parkinson	activates	disease	1.00
Alzheimer	activates	disease	1.00
Als	treats	disease	1.00
MICROGLIA	causes	gene	1.00
Stroke	associated_with	disease	1.00
Microrna	regulates	pathway	1.00
Neurodegeneration	biomarker_for	disease	1.00
Als	associated_with	disease	1.00
Inflammation	associated_with	disease	1.00
Blood-Brain Barrier	therapeutic_target	pathway	1.00
Aging	therapeutic_target	disease	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
NEURON	associated_with	gene	1.00
Amyotrophic Lateral Sclerosis	associated_with	disease	1.00
Alzheimer	causes	disease	1.00

Incoming (6422)

Source	Relation	Type	Str
entities-complement-system	involved_in	wiki	0.00
entities-microglia-in-neurodegeneration	involved_in	wiki	0.00
TAU	associated_with	gene	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
MITOCHONDRIAL DYSFUNCTION	associated_with	gene	1.00
APP/PS1	activates	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
PARKINSON	inhibits	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
TNF	inhibits	gene	1.00
NF-ΚB	inhibits	gene	1.00
MITOCHONDRIAL DYSFUNCTION	associated_with	gene	1.00
OVERVIEW	therapeutic_target	gene	1.00
Als	biomarker_for	disease	1.00
DNA	therapeutic_target	gene	1.00
ALS	associated_with	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
DEMENTIA	associated_with	gene	1.00
ALZHEIMER'S DISEASE	regulates	gene	1.00
TAU	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	associated_with	gene	1.00
BDNF	activates	gene	1.00
PARKINSON'S DISEASE	inhibits	gene	1.00
ERK	activates	gene	1.00
PARKINSON	inhibits	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
NF-ΚB	inhibits	gene	1.00
NEUROINFLAMMATION	biomarker_for	gene	1.00
APP/PS1	activates	gene	1.00
GFAP	activates	gene	1.00
NLRP3	activates	gene	1.00
TAU	therapeutic_target	gene	1.00
GENES	activates	gene	1.00
AKT	therapeutic_target	gene	1.00
PI3K	therapeutic_target	gene	1.00
MICROGLIA	associated_with	gene	1.00
STROKE	associated_with	gene	1.00
TREM2	activates	gene	1.00
GFAP	biomarker_for	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
ASTROCYTES	therapeutic_target	gene	1.00
AGING	associated_with	gene	1.00
NRF2	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
AMYOTROPHIC LATERAL SCLEROSIS	therapeutic_target	gene	1.00
INFLAMMATION	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone	0.808	neurodegeneration	What are the precise temporal dynamics o
SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resil	0.778	neurodegeneration	Gut Microbiome Analysis in Parkinson's D
Microglial Disease-Associated States: TREM2-Independent Path	0.710	neurodegeneration	Cell type vulnerability debate in Alzhei
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut	0.703	neurodegeneration	How do gut microbiome-derived metabolite

AQP4 Dysregulation Promotes Neuroinflammation Through Impair	0.680	neurodegeneration	What are the specific molecular mechanis
GFAP-Bearing Circulating Extracellular Vesicles Originating	0.665	-	What blood-brain barrier permeability ch
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
STING Antagonism Prevents Acute-to-Chronic Neuroinflammation	0.601	neuroinflammation	What molecular mechanisms drive the tran
Cardiovascular-Neuroinflammation Crosstalk Interruption	0.587	Alzheimer's disease	Neuroinflammation and microglial priming
Astrocyte cGAS/STING Activation Converts Protective into Des	0.580	neuroinflammation	How does chronic cGAS/STING activation d
Neuroinflammation-Driven TDP-43 Mislocalization via Microgli	0.580	neurodegeneration	How does APOE4 mechanistically increase
PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflamma	0.571	Neuroinflammation	Immune atlas neuroinflammation analysis
BET Bromodomain Inhibition for Neuroinflammation Suppression	0.550	neurodegeneration	Comparative epigenetic signatures across
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio	0.532	translational neuroscience	Which metabolic biomarkers can distingui
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet	0.510	lipidomics	Lipid metabolism dysregulation in Alzhei
LDLR-Targeted Anti-Inflammatory Antibody Delivery for Neuroi	0.498	neuropharmacology	What is the actual quantitative contribu
Testosterone-Derived DHT Amplifies Microglial Androgen Recep	0.490	neuroinflammation	How do regional, age, and sex-dependent
Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology	0.460	neuroinflammation	How does chronic cGAS/STING activation d
ACSL4-Mediated Neuroinflammatory Amplification in Disease-As	0.459	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
SPI1-Mediated Metabolic Reprogramming in Neuroinflammation	0.455	neuroinflammation	How does SPI1 transcriptionally regulate
SPI1-C1Q Transcriptional Circuit Drives Cerebrovascular Neur	0.455	neuroinflammation	How does SPI1 transcriptionally regulate
Mitophagy Enhancement Blocks STING-Mediated Neuroinflammatio	0.380	Neuroinflammation	Immune atlas neuroinflammation analysis
ω-3 Docosahexaenoic Acid (DHA) Metabolism via 15-Lipoxygenas	0.380	lipidomics	Lipid metabolism dysregulation in Alzhei
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinfla	0.380	neurodegeneration	Spatial Transcriptomics Analysis of Alzh
LDLR-Mediated Neuroinflammation Modulation Strategy	0.380	neuropharmacology	What is the actual quantitative contribu
Age-related neuroinflammation mimics early Alzheimer's disea	0.362	Alzheimer's disease	Allen Mouse Brain Aging Atlas: cross-age
CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab	0.351	developmental neurobiology	Do perinatal immune challenges create pe
plasma LPS-binding protein separates causal from compensator	0.346	neurodegeneration	How does gut microbiome dysbiosis contri
TLR4 priming is the actionable driver in: How does gut micro	0.343	neurodegeneration	How does gut microbiome dysbiosis contri

Mentioning Analyses (27)

Scientific analyses that reference this entity

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.847

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.629

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.597

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.806

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 7 hypotheses Top: 0.752

Experiments (4)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Cerebrovascular function analysis in CD2AP mutant mice	validation	Alzheimer's disease	0.900	mice	proposed	N/A
PGC-1α knockout analysis of PV+ interneuron maturation	validation	neurodevelopmental disorders	0.850	knockout mice	proposed	N/A
Cell-cell interaction analysis of perivascular-microglial crosstalk	exploratory	Alzheimer's disease	0.800	AD mouse models	proposed	N/A
PV+ interneuron subtype diversification analysis	exploratory	neurodevelopmental disorders	0.750	mouse cortical PV+ interneuron	proposed	N/A

Related Papers (17)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949]	Ding YN, Li MQ, Ding PT, Wang P, Guan PP	Nano letters	2026	1
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873]	Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding	Journal of nanobiotechnology	2025	1
Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832]	Ong LT, Sia CH	Current opinion in endocrinolo	2025	1
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911]	Popa E, Popa AE, Poroch M, Poroch V, Ung	International journal of molec	2025	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0
Air pollution, glymphatic impairment, and Alzheimer's disease. [PMID:37777345]	Hussain R, Graham U, Elder A, Nedergaard	Trends in neurosciences	2023	0
Molecular biomarkers for vascular cognitive impairment and dementia. [PMID:37957261]	Hosoki S, Hansra GK, Jayasena T, Poljak	Nature reviews. Neurology	2023	0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938]	Li S, Sun Y, Song M, Song Y, Fang Y, Zha	JCI insight	2021	0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020	0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020	0
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018	0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407]	Gordon R, Albornoz EA, Christie DC, Lang	Science translational medicine	2018	0

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Investigate how microglial senescence drives ALS progression through inflammatio

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the mechanisms by which microglial senescence contributes to ALS pathol

closed · Rounds: 6 · Score: 0.75 · 2026-04-26

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

Related Research

Hypotheses and analyses mentioning NEUROINFLAMMATION in their description or question text

NEUROINFLAMMATION

Understanding Entity Pages

Summary

Wiki Pages (1)

Immune Atlas: Neuroinflammation Analysis

Pathway Diagram

Outgoing (4208)

Incoming (6422)

Targeting Hypotheses (30)

Mentioning Analyses (27)

What are the mechanisms by which microglial senescence contributes to ALS pathol

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

What molecular mechanisms drive the transition from acute to persistent neuroinf

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

Why do TAM receptors protect against neuroinvasive viruses despite their known i

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

How do B cells mechanistically orchestrate tolerance to AQP4 and prevent autoimm

Does reduced Prevotellaceae abundance cause PD pathology or result from it?

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

Why do clinical manifestations overlap despite distinct underlying etiologies in

How does SPI1 transcriptionally regulate C1QA and C1QC expression in atheroscler

Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular effica

Can circadian interventions reverse microglial priming independent of sleep disr

What specific astrocyte-derived factors can 'erase' pathological microglial memo

Senescent cell clearance as neurodegeneration therapy

Which cell types show the most significant expression changes for neurodegenerat

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Gap 006 analysis (archived stub)